A study for a 53 year old woman who takes Femogen, Trazodone Hydrochloride, Sertraline, Lansoprazole, Lysine Hydrochloride, Naproxen (an AI-powered real world drug study)

---

---

Number of reports submitted per year:

Information of the patient in this study:

• Age: 53
• Gender: female

---

Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

• Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood):
  - among females aged 53 (±5) who take the same drugs: 0% (0 of 6)
  - among people who take the same drugs, regardless of gender or age: 0% (0 of 59)
• Asthma:
  - among females aged 53 (±5) who take the same drugs: 0% (0 of 6)
  - among people who take the same drugs, regardless of gender or age: 0% (0 of 59)
• Depression:
  - among females aged 53 (±5) who take the same drugs: 0% (0 of 6)
  - among people who take the same drugs, regardless of gender or age: 0% (0 of 59)
• Menopause (end of monthly cycles in women):
  - among females aged 53 (±5) who take the same drugs: 0% (0 of 6)
  - among people who take the same drugs, regardless of gender or age: 0% (0 of 59)

By each condition:

• people who have Asthma with Menopausal Symptoms:
  - among females aged 53 (±5) who have Menopausal Symptoms: 0.35% (11 of 3,128)
  - among people who have Menopausal Symptoms, regardless of gender or age: 0.4% (35 of 8,798)
• people who have Asthma with Inflammation:
  - among females aged 53 (±5) who have Inflammation: 4.16% (93 of 2,235)
  - among people who have Inflammation, regardless of gender or age: 1.82% (331 of 18,157)
• people who have Asthma with Depression:
  - among females aged 53 (±5) who have Depression: 0.82% (350 of 42,642)
  - among people who have Depression, regardless of gender or age: 0.61% (2,114 of 344,182)
• people who have Depression with Inflammation:
  - among females aged 53 (±5) who have Inflammation: 4.07% (91 of 2,235)
  - among people who have Inflammation, regardless of gender or age: 2.9% (527 of 18,157)
• people who have Depression with Asthma:
  - among females aged 53 (±5) who have Asthma: 2.87% (778 of 27,090)
  - among people who have Asthma, regardless of gender or age: 1.91% (5,328 of 278,476)
• people who have Depression with Menopausal Symptoms:
  - among females aged 53 (±5) who have Menopausal Symptoms: 4.8% (150 of 3,128)
  - among people who have Menopausal Symptoms, regardless of gender or age: 3.4% (299 of 8,798)
• people who have Lymphocytosis with Menopausal Symptoms:
  - among females aged 53 (±5) who have Menopausal Symptoms: 0% (0 of 3,128)
  - among people who have Menopausal Symptoms, regardless of gender or age: 0% (0 of 8,798)
• people who have Lymphocytosis with Inflammation:
  - among females aged 53 (±5) who have Inflammation: 0% (0 of 2,235)
  - among people who have Inflammation, regardless of gender or age: 0.02% (4 of 18,157)
• people who have Lymphocytosis with Asthma:
  - among females aged 53 (±5) who have Asthma: 0.01% (2 of 27,090)
  - among people who have Asthma, regardless of gender or age: 0.01% (21 of 278,476)
• people who have Lymphocytosis with Depression:
  - among females aged 53 (±5) who have Depression: 0.03% (13 of 42,642)
  - among people who have Depression, regardless of gender or age: 0.02% (64 of 344,182)
• people who have Menopause with Inflammation:
  - among females aged 53 (±5) who have Inflammation: 0.13% (3 of 2,235)
  - among people who have Inflammation, regardless of gender or age: 0.05% (9 of 18,157)
• people who have Menopause with Asthma:
  - among females aged 53 (±5) who have Asthma: 0.07% (20 of 27,090)
  - among people who have Asthma, regardless of gender or age: 0.01% (39 of 278,476)
• people who have Menopause with Menopausal Symptoms:
  - among females aged 53 (±5) who have Menopausal Symptoms: 0.19% (6 of 3,128)
  - among people who have Menopausal Symptoms, regardless of gender or age: 0.1% (9 of 8,798)
• people who have Menopause with Depression:
  - among females aged 53 (±5) who have Depression: 0.06% (27 of 42,642)
  - among people who have Depression, regardless of gender or age: 0.03% (118 of 344,182)

By each drug (FDA data only):

• people who take Lansoprazole and have Asthma:
  - among females aged 53 (±5) who take Lansoprazole and have side effects: 1.2% (108 of 9,023)
  - among people who take Lansoprazole and have side effects, regardless of gender or age: 1.4% (1,799 of 128,099)
• people who take Trazodone Hydrochloride and have Asthma:
  - among females aged 53 (±5) who take Trazodone Hydrochloride and have side effects: 4.41% (88 of 1,997)
  - among people who take Trazodone Hydrochloride and have side effects, regardless of gender or age: 1.4% (243 of 17,399)
• people who take Lysine Hydrochloride and have Asthma:
  - among females aged 53 (±5) who take Lysine Hydrochloride and have side effects: 0% (0 of 5)
  - among people who take Lysine Hydrochloride and have side effects, regardless of gender or age: 1.83% (2 of 109)
• people who take Naproxen and have Asthma:
  - among females aged 53 (±5) who take Naproxen and have side effects: 2.01% (176 of 8,756)
  - among people who take Naproxen and have side effects, regardless of gender or age: 1.46% (1,005 of 68,964)
• people who take Femogen and have Asthma:
  - among females aged 53 (±5) who take Femogen and have side effects: 0% (0 of 0)
  - among people who take Femogen and have side effects, regardless of gender or age: 0% (0 of 0)
• people who take Sertraline and have Asthma:
  - among females aged 53 (±5) who take Sertraline and have side effects: 0.7% (87 of 12,449)
  - among people who take Sertraline and have side effects, regardless of gender or age: 0.98% (1,435 of 146,484)
• people who take Femogen and have Depression:
  - among females aged 53 (±5) who take Femogen and have side effects: 0% (0 of 0)
  - among people who take Femogen and have side effects, regardless of gender or age: 0% (0 of 0)
• people who take Trazodone Hydrochloride and have Depression:
  - among females aged 53 (±5) who take Trazodone Hydrochloride and have side effects: 6.66% (133 of 1,997)
  - among people who take Trazodone Hydrochloride and have side effects, regardless of gender or age: 4.81% (837 of 17,399)
• people who take Sertraline and have Depression:
  - among females aged 53 (±5) who take Sertraline and have side effects: 5.08% (632 of 12,449)
  - among people who take Sertraline and have side effects, regardless of gender or age: 4.68% (6,851 of 146,484)
• people who take Lansoprazole and have Depression:
  - among females aged 53 (±5) who take Lansoprazole and have side effects: 2.19% (198 of 9,023)
  - among people who take Lansoprazole and have side effects, regardless of gender or age: 1.5% (1,923 of 128,099)
• people who take Lysine Hydrochloride and have Depression:
  - among females aged 53 (±5) who take Lysine Hydrochloride and have side effects: 0% (0 of 5)
  - among people who take Lysine Hydrochloride and have side effects, regardless of gender or age: 2.75% (3 of 109)
• people who take Naproxen and have Depression:
  - among females aged 53 (±5) who take Naproxen and have side effects: 3.75% (328 of 8,756)
  - among people who take Naproxen and have side effects, regardless of gender or age: 3.38% (2,332 of 68,964)
• people who take Naproxen and have Lymphocytosis:
  - among females aged 53 (±5) who take Naproxen and have side effects: 0.05% (4 of 8,756)
  - among people who take Naproxen and have side effects, regardless of gender or age: 0.02% (12 of 68,964)
• people who take Lysine Hydrochloride and have Lymphocytosis:
  - among females aged 53 (±5) who take Lysine Hydrochloride and have side effects: 0% (0 of 5)
  - among people who take Lysine Hydrochloride and have side effects, regardless of gender or age: 0% (0 of 109)
• people who take Lansoprazole and have Lymphocytosis:
  - among females aged 53 (±5) who take Lansoprazole and have side effects: 0.07% (6 of 9,023)
  - among people who take Lansoprazole and have side effects, regardless of gender or age: 0.02% (22 of 128,099)
• people who take Femogen and have Lymphocytosis:
  - among females aged 53 (±5) who take Femogen and have side effects: 0% (0 of 0)
  - among people who take Femogen and have side effects, regardless of gender or age: 0% (0 of 0)
• people who take Sertraline and have Lymphocytosis:
  - among females aged 53 (±5) who take Sertraline and have side effects: 0% (0 of 12,449)
  - among people who take Sertraline and have side effects, regardless of gender or age: 0.01% (17 of 146,484)
• people who take Trazodone Hydrochloride and have Lymphocytosis:
  - among females aged 53 (±5) who take Trazodone Hydrochloride and have side effects: 0% (0 of 1,997)
  - among people who take Trazodone Hydrochloride and have side effects, regardless of gender or age: 0.01% (1 of 17,399)
• people who take Naproxen and have Menopause:
  - among females aged 53 (±5) who take Naproxen and have side effects: 0.14% (12 of 8,756)
  - among people who take Naproxen and have side effects, regardless of gender or age: 0.03% (22 of 68,964)
• people who take Lansoprazole and have Menopause:
  - among females aged 53 (±5) who take Lansoprazole and have side effects: 0.04% (4 of 9,023)
  - among people who take Lansoprazole and have side effects, regardless of gender or age: 0.01% (9 of 128,099)
• people who take Sertraline and have Menopause:
  - among females aged 53 (±5) who take Sertraline and have side effects: 0.19% (24 of 12,449)
  - among people who take Sertraline and have side effects, regardless of gender or age: 0.03% (51 of 146,484)
• people who take Femogen and have Menopause:
  - among females aged 53 (±5) who take Femogen and have side effects: 0% (0 of 0)
  - among people who take Femogen and have side effects, regardless of gender or age: 0% (0 of 0)
• people who take Lysine Hydrochloride and have Menopause:
  - among females aged 53 (±5) who take Lysine Hydrochloride and have side effects: 0% (0 of 5)
  - among people who take Lysine Hydrochloride and have side effects, regardless of gender or age: 0% (0 of 109)
• people who take Trazodone Hydrochloride and have Menopause:
  - among females aged 53 (±5) who take Trazodone Hydrochloride and have side effects: 0.1% (2 of 1,997)
  - among people who take Trazodone Hydrochloride and have side effects, regardless of gender or age: 0.08% (14 of 17,399)

Common drug interactions *:

1. Drug Hypersensitivity : 2 people, 33.33%
2. Rashes (redness): 2 people, 33.33%
3. Nausea (feeling of having an urge to vomit): 2 people, 33.33%
4. Nausea And Vomiting : 2 people, 33.33%
5. Joint Pain : 2 people, 33.33%
6. Oedema Peripheral (superficial swelling): 2 people, 33.33%
7. Pain In Extremity : 2 people, 33.33%
8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 33.33%
9. Dizziness : 2 people, 33.33%
10. Muscle Aches (muscle pain): 2 people, 33.33%
11. Abdominal Pain : 2 people, 33.33%
12. Acute Kidney Failure : 2 people, 33.33%
13. Headache (pain in head): 2 people, 33.33%
14. Faecal Incontinence (a lack of control over passing stool): 1 person, 16.67%
15. Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 1 person, 16.67%
16. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 16.67%
17. Dehydration (dryness resulting from the removal of water): 1 person, 16.67%
18. Dental Caries : 1 person, 16.67%
19. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 16.67%
20. Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 1 person, 16.67%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 33.33%
2. Weight Decreased : 1 person, 16.67%
3. Pulmonary Congestion (congestion in the lungs): 1 person, 16.67%
4. Osteoporosis (bones weak and more likely to break): 1 person, 16.67%
5. Joint Pain : 1 person, 16.67%
6. Impaired Gastric Emptying : 1 person, 16.67%
7. Diabetes : 1 person, 16.67%
8. Cough : 1 person, 16.67%
9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 16.67%
10. Chest Pain : 1 person, 16.67%
11. Bipolar Disorder (mood disorder): 1 person, 16.67%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

1. Ultram (3 people, 50.00%)
2. Prilosec (3 people, 50.00%)
3. Nexium (3 people, 50.00%)
4. Lortab (2 people, 33.33%)
5. Stadol (2 people, 33.33%)
6. Ibuprofen (2 people, 33.33%)
7. Clonidine (2 people, 33.33%)
8. Triamcinolone (2 people, 33.33%)
9. Phenergan (2 people, 33.33%)
10. Keflex (2 people, 33.33%)
11. Demerol (2 people, 33.33%)
12. Actonel (2 people, 33.33%)
13. Methotrexate (2 people, 33.33%)
14. Calcium (2 people, 33.33%)
15. Metformin (2 people, 33.33%)
16. Mepergan (2 people, 33.33%)
17. Zolpidem (2 people, 33.33%)
18. Gaviscon (2 people, 33.33%)
19. Lisinopril (2 people, 33.33%)
20. Advair Hfa (2 people, 33.33%)

Drug effectiveness *:

---